Chapter 1 Therapeutic oligonucleotides.

Chapter 2 Therapeutic Oligonucleotides

Chapter 3 2′-O,4′-C-Methyleneoxymethylene Bridged Nucleic Acids (2′,4′-BNACOC)

Chapter 4 A Non-covalent Peptide-Based Strategy for Ex Vivo and In Vivo Oligonucleotide Delivery.

Chapter 5 Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.

Chapter 6 A nanoparticle for tumor targeted delivery of oligomers.

Chapter 7 Light-Directed Delivery of Nucleic Acids

Chapter 8 Antibody Targeted siRNA Delivery.

Chapter 9 Aptamer-drug conjugation for targeted tumor cell therapy.

Chapter 10 Five-Step Process for Screening Antisense Compounds for Efficacy: Gene Target IL-12Rb2

Chapter 11 Diverse Small Non-coding RNAs in RNA Interference Pathways.

Chapter 12 Quantification of siRNAs In Vitro and In Vivo.

Chapter 13 Optimization of Transfection Conditions and Analysis of siRNA Potency Using Real-time PCR.

Chapter 14 siRNA Knockdown of Gene Expression in Endothelial Cells.

Chapter 15 Using RNA Interference in Schistosoma mansoni

Chapter 16 Performing the Labeled microRNA Pull-Down (LAMP) Assay System: An Experimental Approach for High-Throughput Identification of microRNA-Target mRNAs.

Chapter 17 Synthesis, Purification, and Characterization of Oligoribonucleotides that Act as Agonists of TLR7 and/or TLR8

Chapter 18 Synthesis, Purification, and Characterization of Immune-Modulatory Oligodeoxynucleotides that Act as Agonists of Toll-Like Receptor 9

Chapter 19 Surface Plasmon Resonance Investigation of RNA Aptamer–RNA Ligand Interactions

Chapter 20 Practical Considerations for Analyzing Antigene RNAs (agRNAs): RNA Immunoprecipitation of Argonaute Protein

Chapter 21 Inhibition of Human Papillomavirus Expression Using DNAzymes